These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16282396)

  • 1. FDA investigates direct to consumer adverts.
    Lenzer J
    BMJ; 2005 Nov; 331(7525):1102. PubMed ID: 16282396
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA tightens rules on advertising.
    Josefson D
    BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct-to-consumer prescription drug advertising.
    Terzian TV
    Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
    [No Abstract]   [Full Text] [Related]  

  • 5. US aims to tighten rules on direct-to-consumer drug ads.
    Vastag B
    Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct-to-consumer advertising of drugs.
    Weinmeyer R
    Virtual Mentor; 2013 Nov; 15(11):954-8. PubMed ID: 24257087
    [No Abstract]   [Full Text] [Related]  

  • 7. Advertisements. FDA orders Abbott to change misleading ads for Norvir.
    AIDS Policy Law; 2004 Jul; 19(12):9. PubMed ID: 15282864
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug risks and free speech--can Congress ban consumer drug ads?
    Shuchman M
    N Engl J Med; 2007 May; 356(22):2236-9. PubMed ID: 17476002
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN
    J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA questions San Francisco HIV/AIDS drug advertisements.
    AIDS Policy Law; 2001 May; 16(9):1, 6. PubMed ID: 11668819
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
    Allen MC
    Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-39. PubMed ID: 21374841
    [No Abstract]   [Full Text] [Related]  

  • 13. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER
    N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
    [No Abstract]   [Full Text] [Related]  

  • 14. The new drug marketing: a consumer protection perspective.
    Woodward D
    Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733
    [No Abstract]   [Full Text] [Related]  

  • 15. Health related claims, the market for information, and the first amendment.
    Beales JH
    Health Matrix Clevel; 2011; 21(1):7-30. PubMed ID: 21847896
    [No Abstract]   [Full Text] [Related]  

  • 16. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
    Waxman HA
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-256-8. PubMed ID: 15452002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online healthcare advertising needs regulation.
    Masoni M; Guelfi MR; Gensini GF
    BMJ; 2011 Mar; 342():c5778. PubMed ID: 21372072
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA's restrictions against prescription drug advertising: more hindrance than help.
    Lorman AJ
    Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives. New twist on guideline dissemination stirs professional debate, gets slap from FDA.
    Newman L
    Med Health; 1999 Feb; 53(8):suppl 1-4. PubMed ID: 10345551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.